Tag: Bharat Biotech
Browse our exclusive articles!
Bharat Biotech’s Covid nasal vaccine phase 3 trials completed
The clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine have been completed and the company will submit its data to...
Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants: ICMR study
A booster dose of Covaxin enhances vaccine effectiveness against the Delta variant of COVID-19 and gives protection against Omicron variants BA.1.1 and BA.2,...
Covaxin to be recognised by Germany for travel from June 1
Germany will begin to recognise Covaxin for travel purpose from next Wednesday. The Indian-developed Covid-19 vaccine from Bharat Biotech will be recognised the...
Will Covid-19 nasal vaccine prove effective against infection? AIIMS expert says THIS
As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster...
DCGI approves for Bharat Biotech to conduct intranasal booster dose trials
The DGCI has approved Covaxin manufacturer, Bharat Biotech's Phase-III clinical trials for the intranasal booster dose BBV154 (Nasal covid vaccine) on individuals who...
